Free tool
Drug Trial Radar: Neurology
Last checked: Nov 20, 2026Latest source record: Nov 17, 2026 (registry update on this page)ClinicalTrials.gov last updated: Nov 20, 2026Methods & limitations
Filters
Filters are saved in the page address, so a filtered view can be bookmarked or shared.
Matching drug trials
4
Not yet recruiting, industry sponsors, Neurology, Phase 4 (post-approval)
By trial status
The same filters, counted in each status. Pick one to switch.
- Completed274
4 trials
Showing 1 to 4, recently updated first.
- A Study to Investigate the Effect of Gradual Titration to Optimize Cannabidiol Treatment in Adults With LGSNot yet recruiting
Jazz PharmaceuticalsJazz Pharmaceuticals (JAZZ)
NCT07728097 · 40 participants (planned) · Start Nov 18, 2026 · Primary completion Dec 28, 2028
Drug: Cannabidiol Oral Solution · For: Lennox-Gastaut Syndrome
Sites: Fresno, California; New Orleans, Louisiana; Raleigh, North Carolina
- A Study of Donanemab (LY3002813) in Participants With Early Symptomatic Alzheimer's DiseaseNot yet recruiting
Eli Lilly and CompanyEli Lilly (LLY)
NCT07838155 · 50 participants (planned) · Start Nov 2026 · Primary completion Sep 2030
Drug: Donanemab · For: Alzheimer Disease
Sites: Bangalore, India; Hyderabad, India; Kolkata, India · 12 sites in all
- Study of the Pharmacokinetics, Safety, and Tolerability of ZONISADE in Children 1 Month to 17 Years of Age With Partial-onset SeizuresNot yet recruiting
Azurity PharmaceuticalsIndustry
NCT06534502 · 40 participants (planned) · Start Sep 2026 · Primary completion Sep 2027
Drug: Zonisamide Oral Product · For: Seizures; Seizures, Focal; Seizure, Partial Onset and 4 more
Sites: Winston-Salem, North Carolina; Memphis, Tennessee
- A Phase IV Study of Dimethyl Fumarate Enteric-coated Capsules for Relapsing Multiple Sclerosis (RMS)Not yet recruiting
Qilu Pharmaceutical (Hainan) Co., Ltd.Industry
NCT07138833 · 50 participants (planned) · Start Sep 2025 · Primary completion Apr 2028
Drug: Dimethyl Fumarate Enteric-coated Capsules · For: Relapsing Multiple Sclerosis
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.